Showing results (71-80 of 422) with videos related to
Sort By:
Pageof 43
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 25, 2012
Peptide receptor radionuclide therapy with (177)Lu labeled somatostatin analogs DOTATATE and DOTATOC: contrasting renal dosimetry in the same patientHarshad R Kulkarni, Christiane Schuchardt, Richard P BaumFrontiers in Medicine|October 24, 2024
Extraordinary therapeutic effect of PSMA radioligand therapy in treatment-refractory progressive metastatic prostate cancer with the transketolase inhibitor benfo-oxythiamine as a radiosensitizer-A case reportCarsten S Kramer, Jingjing Zhang, Richard P BaumDer Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|November 22, 2001
[Anetoderma Schwenninger-Buzzi in a dark-skinned patient]J M Pönnighaus, G Jaeger, H P BaumOptics Letters|March 27, 2003
Phase-coherent generation of tunable visible femtosecond pulsesP Baum, S Lochbrunner, J Piel, et al.PET Clinics|March 8, 2017
Imaging of Prostate Cancer Using 64Cu-Labeled Prostate-Specific Membrane Antigen LigandAviral Singh, Harshad R Kulkarni, Richard P BaumRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 25, 2012
Rare metastases detected by (68)Ga-somatostatin receptor PET/CT in patients with neuroendocrine tumorsCecilia Carreras, Harshad R Kulkarni, Richard P BaumDer Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|March 26, 2002
[Cutaneous manifestation of cysticercosis]J M Pönnighaus, P Nkhosa, H P BaumAnnals of Translational Medicine|October 22, 2014
THERANOSTICS-clinical aimshots in surgical warfare against well-differentiated neuroendocrine neoplasmsDieter Hörsch, Harshad R Kulkarni, Richard P BaumClinical Nuclear Medicine|January 25, 2020
Peptide Receptor Radionuclide Therapy Using 225Ac-DOTATOC Achieves Partial Remission in a Patient With Progressive Neuroendocrine Liver Metastases After Repeated β-Emitter Peptide Receptor Radionuclide TherapyJingjing Zhang, Harshad R Kulkarni, Richard P BaumClinical Nuclear Medicine|July 9, 2021
225Ac-DOTATOC-Targeted Somatostatin Receptor α-Therapy in a Patient With Metastatic Neuroendocrine Tumor of the Thymus, Refractory to β-RadiationJingjing Zhang, Harshad R Kulkarni, Richard P BaumPageof 43